Patients with coronary artery disease who need treatment for high blood pressure gain similar benefits whether their treatment regimen is based on a calcium channel blocker or on a beta blocker, study data indicate. The study compared multidrug strategies based either on verapamil or atenolol in a trial of 22,576 hypertensive patients with coronary artery disease. After an average of 2.7 years, incidence of non-fatal heart attack, non-fatal stroke or death was similar for both treatment strategies.
展开▼
